The University of Southampton
University of Southampton Institutional Repository

Metabolic dysfunction-associated fatty liver disease is associated with greater impairment of lung function than nonalcoholic fatty liver disease

Metabolic dysfunction-associated fatty liver disease is associated with greater impairment of lung function than nonalcoholic fatty liver disease
Metabolic dysfunction-associated fatty liver disease is associated with greater impairment of lung function than nonalcoholic fatty liver disease

Background and Aims: We compared lung function parameters in nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD), and examined the association between lung function parameters and fibrosis severity in MAFLD. Meth-ods: In this cross-sectional study, we randomly recruited 2,543 middle-aged individuals from 25 communities across four cities in China during 2016 and 2020. All participants received a health check-up including measurement of anthropometric parameters, biochemical variables, liver ultrasonography, and spirometry. The severity of liver disease was assessed by the fibrosis (FIB)-4 score. Results: The prevalence of MAFLD was 20.4% (n=519) and that of NAFLD was 18.4% (n=469). After adjusting for age, sex, adiposity measures, smoking status, and significant alcohol intake, subjects with MAFLD had a significantly lower predicted forced vital capacity (FVC, 88.27±17.60% vs. 90.82±16.85%, p<0.05) and lower 1 s forced expiratory volume (FEV 1, 79.89±17.34 vs. 83.02±16.66%, p<0.05) than those with NAFLD. MAFLD with an increased FIB-4 score was significantly associated with decreased lung function. For each 1-point increase in FIB-4, FVC was diminished by 0.507 (95% CI: −0.840, −0.173, p=0.003), and FEV 1 was diminished by 0.439 (95% CI: −0.739, −0.140, p=0.004). The results remained unchanged when the statistical analyses was performed separately for men and women. Conclusions: MAFLD was significantly associated with a greater impairment of lung function parameters than NAFLD.

Liver fibrosis score, Lung function, MAFLD, NAFLD
2225-0719
230-237
Miao, Lei
a2d40d6d-be2f-43af-8d73-7a2f0008b93b
Yang, Li
7763d46c-9b56-44e0-b1e4-d2f0b4024477
Guo, Li-Sha
5cc77582-214c-43ff-bf39-b02eff7eafd8
Shi, Qiang-Qiang
4c411f4b-4201-49d0-883c-aeaa24d00200
Zhou, Teng-Fei
ed2afefe-b7b2-42c7-973c-4f7f76303252
Chen, Yang
6872f40e-e317-442e-af2f-962e5435d60a
Zhang, Huai
70fb811f-e45a-44a3-8af1-15f3c4a84ad2
Cai, Hui
9b04f18d-cd54-4f38-b406-b81518c67395
Xu, Zhi-Wei
06cf7874-7f61-4ff3-9ca7-2829daf250fb
Yang, Shuan-Ying
6b177f36-7c1b-4906-823f-62f67c973e39
Lin, Hai
a4f9f39c-ce86-48de-92d0-12e936be405d
Cheng, Zhe
2fb3d9bf-92e4-4685-8e67-e66eb08e19a4
Zhu, Ming-Yang
11079500-db41-4ee0-a8e2-e79411de1a01
Nan, Xu
3358fc7d-4c25-499b-a5f7-76daa787e7b6
Huang, Shuai
1a1d3e84-b95b-4bf4-86fb-57197f98dc31
Zheng, Ya-Wen
c0210cfd-97d3-4288-a462-c6cd8173cb92
Targher, Giovanni
53e51766-15b0-4bad-9956-e1462fe4061f
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Li, Yu-Ping
e98e3dca-39d1-4bef-8b25-714c7bc70054
Zheng, Ming-Hua
07dd87d9-5bbc-4ce6-b8a4-17f45ce0208f
Chen, Cheng-Shui
88f9270f-55a0-4a6f-b6d3-a1ac1a361900
Miao, Lei
a2d40d6d-be2f-43af-8d73-7a2f0008b93b
Yang, Li
7763d46c-9b56-44e0-b1e4-d2f0b4024477
Guo, Li-Sha
5cc77582-214c-43ff-bf39-b02eff7eafd8
Shi, Qiang-Qiang
4c411f4b-4201-49d0-883c-aeaa24d00200
Zhou, Teng-Fei
ed2afefe-b7b2-42c7-973c-4f7f76303252
Chen, Yang
6872f40e-e317-442e-af2f-962e5435d60a
Zhang, Huai
70fb811f-e45a-44a3-8af1-15f3c4a84ad2
Cai, Hui
9b04f18d-cd54-4f38-b406-b81518c67395
Xu, Zhi-Wei
06cf7874-7f61-4ff3-9ca7-2829daf250fb
Yang, Shuan-Ying
6b177f36-7c1b-4906-823f-62f67c973e39
Lin, Hai
a4f9f39c-ce86-48de-92d0-12e936be405d
Cheng, Zhe
2fb3d9bf-92e4-4685-8e67-e66eb08e19a4
Zhu, Ming-Yang
11079500-db41-4ee0-a8e2-e79411de1a01
Nan, Xu
3358fc7d-4c25-499b-a5f7-76daa787e7b6
Huang, Shuai
1a1d3e84-b95b-4bf4-86fb-57197f98dc31
Zheng, Ya-Wen
c0210cfd-97d3-4288-a462-c6cd8173cb92
Targher, Giovanni
53e51766-15b0-4bad-9956-e1462fe4061f
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Li, Yu-Ping
e98e3dca-39d1-4bef-8b25-714c7bc70054
Zheng, Ming-Hua
07dd87d9-5bbc-4ce6-b8a4-17f45ce0208f
Chen, Cheng-Shui
88f9270f-55a0-4a6f-b6d3-a1ac1a361900

Miao, Lei, Yang, Li, Guo, Li-Sha, Shi, Qiang-Qiang, Zhou, Teng-Fei, Chen, Yang, Zhang, Huai, Cai, Hui, Xu, Zhi-Wei, Yang, Shuan-Ying, Lin, Hai, Cheng, Zhe, Zhu, Ming-Yang, Nan, Xu, Huang, Shuai, Zheng, Ya-Wen, Targher, Giovanni, Byrne, Christopher, Li, Yu-Ping, Zheng, Ming-Hua and Chen, Cheng-Shui (2022) Metabolic dysfunction-associated fatty liver disease is associated with greater impairment of lung function than nonalcoholic fatty liver disease. Journal of Clinical and Translational Hepatology, 10 (2), 230-237. (doi:10.14218/JCTH.2021.00306).

Record type: Article

Abstract

Background and Aims: We compared lung function parameters in nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD), and examined the association between lung function parameters and fibrosis severity in MAFLD. Meth-ods: In this cross-sectional study, we randomly recruited 2,543 middle-aged individuals from 25 communities across four cities in China during 2016 and 2020. All participants received a health check-up including measurement of anthropometric parameters, biochemical variables, liver ultrasonography, and spirometry. The severity of liver disease was assessed by the fibrosis (FIB)-4 score. Results: The prevalence of MAFLD was 20.4% (n=519) and that of NAFLD was 18.4% (n=469). After adjusting for age, sex, adiposity measures, smoking status, and significant alcohol intake, subjects with MAFLD had a significantly lower predicted forced vital capacity (FVC, 88.27±17.60% vs. 90.82±16.85%, p<0.05) and lower 1 s forced expiratory volume (FEV 1, 79.89±17.34 vs. 83.02±16.66%, p<0.05) than those with NAFLD. MAFLD with an increased FIB-4 score was significantly associated with decreased lung function. For each 1-point increase in FIB-4, FVC was diminished by 0.507 (95% CI: −0.840, −0.173, p=0.003), and FEV 1 was diminished by 0.439 (95% CI: −0.739, −0.140, p=0.004). The results remained unchanged when the statistical analyses was performed separately for men and women. Conclusions: MAFLD was significantly associated with a greater impairment of lung function parameters than NAFLD.

Text
Draft_R1_clean - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (392kB)
Image
Figure 1_R1 - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (122kB)
Text
Table_1_R1 - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (129kB)
Text
Table_2_R1 - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Table_3_R1 - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Table_4_R1 - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Table_S1_R1 - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Table_S2_R1 - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Table_S3_R1 - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Table_S4_R1 - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Table_S5_R1 - Accepted Manuscript
Restricted to Repository staff only
Request a copy

Show all 11 downloads.

More information

Accepted/In Press date: 9 November 2021
e-pub ahead of print date: 28 April 2022
Published date: 28 April 2022
Additional Information: Funding Information: This study was supported by the National Key Research and Development Program of China (No: 2016YFC1304000), National Natural Science Foundation of China (82000690), High Level Creative Talents from Department of Public Health in Zhejiang Province, and the Key Research and Development Program of Zhejiang Province (No: 2019C03030). GT was supported in part by grants from the University School of Medicine of Verona, Verona, Italy. CDB was supported in part by the Southampton National Institute for Health Research Biomedical Research Center. Publisher Copyright: © 2022 The Author(s).
Keywords: Liver fibrosis score, Lung function, MAFLD, NAFLD

Identifiers

Local EPrints ID: 452218
URI: http://eprints.soton.ac.uk/id/eprint/452218
ISSN: 2225-0719
PURE UUID: 7ad4d01d-5463-461b-8ce3-2b252d6e7209
ORCID for Christopher Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 30 Nov 2021 17:32
Last modified: 17 Mar 2024 06:56

Export record

Altmetrics

Contributors

Author: Lei Miao
Author: Li Yang
Author: Li-Sha Guo
Author: Qiang-Qiang Shi
Author: Teng-Fei Zhou
Author: Yang Chen
Author: Huai Zhang
Author: Hui Cai
Author: Zhi-Wei Xu
Author: Shuan-Ying Yang
Author: Hai Lin
Author: Zhe Cheng
Author: Ming-Yang Zhu
Author: Xu Nan
Author: Shuai Huang
Author: Ya-Wen Zheng
Author: Giovanni Targher
Author: Yu-Ping Li
Author: Ming-Hua Zheng
Author: Cheng-Shui Chen

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×